Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-19-002012

SVP, Chief Medical Officer bought 1,104 shares at an average $4.92 ($5,436)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meyers Michael L. SVP, Chief Medical Officer 2019-03-21 Purchase +1,000 $4.93 $4,930 7,118 D
Meyers Michael L. SVP, Chief Medical Officer 2019-03-21 Purchase +104 $4.87 $506 7,222 D
Open-market purchases · 1,104 sh · avg $4.92 · $5,436
Loading xslF345X03/primarydocument.xml…